{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:00:27Z","timestamp":1786982427274,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biophys Rev"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12551-026-01405-2","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:57:44Z","timestamp":1769515064000},"page":"1781-1794","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predicting and monitoring treatment response via 1-H NMR metabolomics of plasma, serum, and urine"],"prefix":"10.1007","volume":"17","author":[{"given":"Shashikant","family":"Kotwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Wook","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tedros","family":"Bezabeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"1405_CR1","doi-asserted-by":"publisher","unstructured":"Andrew Clayton T, Lindon JC, Cloarec O, Antti H, Charuel C, Hanton et al (2006) Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 440(7087):1073\u20131077. https:\/\/doi.org\/10.1038\/nature04648","DOI":"10.1038\/nature04648"},{"issue":"1","key":"1405_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ab.2006.04.014","volume":"355","author":"N Aran\u0131\u00b4bar","year":"2006","unstructured":"Aran\u0131\u00b4bar N, Ott K, Roongta V, Mueller L (2006) Metabolomic analysis using optimized NMR and statistical methods. Anal Biochem 355(1):62\u201370. https:\/\/doi.org\/10.1016\/j.ab.2006.04.014","journal-title":"Anal Biochem"},{"issue":"4","key":"1405_CR3","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s00216-012-6188-z","volume":"404","author":"GA Barding","year":"2012","unstructured":"Barding GA, Salditos R, Larive CK (2012) Quantitative NMR for bioanalysis and metabolomics. Anal Bioanal Chem 404(4):1165\u20131179. https:\/\/doi.org\/10.1007\/s00216-012-6188-z","journal-title":"Anal Bioanal Chem"},{"issue":"3","key":"1405_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/cem.785","volume":"17","author":"M Barker","year":"2003","unstructured":"Barker M, Rayens W (2003) Partial least squares for discrimination. J Chemometr 17(3):166\u2013173. https:\/\/doi.org\/10.1002\/cem.785","journal-title":"J Chemometr"},{"issue":"11","key":"1405_CR5","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/nprot.2007.376","volume":"2","author":"O Beckonert","year":"2007","unstructured":"Beckonert O, Keun HC, Ebbels TM, Bundy J, Holmes E, Lindon JC, Nicholson JK (2007) Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2(11):2692\u20132703. https:\/\/doi.org\/10.1038\/nprot.2007.376","journal-title":"Nat Protoc"},{"key":"1405_CR6","doi-asserted-by":"publisher","unstructured":"Bezabeh T, Capati A, Ijare OB (2019) NMR-based urinary metabolomics applications. NMR-Based Metabolomics Methods in Molecular Biology, pp 215\u2013229. https:\/\/doi.org\/10.1007\/978-1-4939-9690-2_13","DOI":"10.1007\/978-1-4939-9690-2_13"},{"key":"1405_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.trac.2012.02.007","volume":"35","author":"SK Bharti","year":"2012","unstructured":"Bharti SK, Roy R (2012) Quantitative 1H NMR spectroscopy. TrAC Trends Anal Chem 35:5\u201326. https:\/\/doi.org\/10.1016\/j.trac.2012.02.007","journal-title":"TrAC Trends Anal Chem"},{"issue":"8","key":"1405_CR8","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.1021\/pr300459d","volume":"11","author":"H Cai","year":"2012","unstructured":"Cai H, Li H, Yan X, Sun B, Zhang Q, Yan M et al (2012) Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-na\u00efve schizophrenia patients after treatment with risperidone. J Proteome Res 11(8):4338\u20134350. https:\/\/doi.org\/10.1021\/pr300459d","journal-title":"J Proteome Res"},{"key":"1405_CR9","doi-asserted-by":"publisher","unstructured":"Capati A, Ijare OB, Bezabeh T (2017) Diagnostic applications of nuclear magnetic resonance\u2013based urinary metabolomics. Magn Reson Insights. https:\/\/doi.org\/10.1177\/1178623x17694346","DOI":"10.1177\/1178623x17694346"},{"key":"1405_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12040357","volume":"12","author":"Y Chen","year":"2022","unstructured":"Chen Y, Li EM, Xu LY (2022) Guide to metabolomics analysis: a bioinformatics workflow. Metabolites 12:357. https:\/\/doi.org\/10.3390\/metabo12040357","journal-title":"Metabolites"},{"issue":"6","key":"1405_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/metabo9060117","volume":"9","author":"S Chu","year":"2019","unstructured":"Chu S, Huang M, Kelly R, Benedetti E, Siddiqui J, Zeleznik O et al (2019) Integration of metabolomic and other omics data in population-based study designs: an epidemiological perspective. Metabolites 9(6):117. https:\/\/doi.org\/10.3390\/metabo9060117","journal-title":"Metabolites"},{"key":"1405_CR12","doi-asserted-by":"publisher","unstructured":"Emwas AHM (2015) The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research. Metabonomics :161\u2013193.  https:\/\/doi.org\/10.1007\/978-1-4939-2377-9_13","DOI":"10.1007\/978-1-4939-2377-9_13"},{"issue":"2","key":"1405_CR13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1021\/acs.jproteome.5b00885","volume":"15","author":"AH Emwas","year":"2016","unstructured":"Emwas AH, Roy R, McKay RT, Ryan D, Brennan L, Tenori L et al (2016) Recommendations and standardization of biomarker quantification using NMR-based metabolomics with particular focus on urinary analysis. J Proteome Res 15(2):360\u2013373. https:\/\/doi.org\/10.1021\/acs.jproteome.5b00885","journal-title":"J Proteome Res"},{"issue":"3","key":"1405_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-025-02259-7","volume":"21","author":"AH Emwas","year":"2025","unstructured":"Emwas AH, Zacharias HU, Alborghetti MR, Gowda GAN, Raftery D, McKay RT et al (2025) Recommendations for sample selection, collection and preparation for NMR-based metabolomics studies of blood. Metabolomics 21(3):66. https:\/\/doi.org\/10.1007\/s11306-025-02259-7","journal-title":"Metabolomics"},{"issue":"1","key":"1405_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/ki.1993.37","volume":"43","author":"PJD Foxall","year":"1993","unstructured":"Foxall PJD, Mellotte GJ, Bending MR, Lindon JC, Nicholson JK (1993) NMR spectroscopy as a novel approach to the monitoring of renal transplant function. Kidney Int 43(1):234\u2013245. https:\/\/doi.org\/10.1038\/ki.1993.37","journal-title":"Kidney Int"},{"issue":"11","key":"1405_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140993","volume":"10","author":"M Garcia-Simon","year":"2015","unstructured":"Garcia-Simon M, Morales JM, Modesto-Alapont V, Gonzalez-Marrachelli V, Vento-Rehues R, Jorda-Mi\u00f1ana A et al (2015) Prognosis biomarkers of severe sepsis and septic shock by 1-H NMR urine metabolomics in the intensive care unit. PLoS ONE 10(11):e0140993. https:\/\/doi.org\/10.1371\/journal.pone.0140993","journal-title":"PLoS ONE"},{"key":"1405_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/metabo10060229","volume":"10","author":"R Gonzalez-Dominguez","year":"2020","unstructured":"Gonzalez-Dominguez R, Gonzalez-Dominguez A, Sayago A, Fernandez-Recamales A (2020) Recommendations and best practices for standardizing the pre-analytical processing of blood and urine samples in metabolomics. Metabolites 10:229.\u00a0https:\/\/doi.org\/10.3390\/metabo10060229","journal-title":"Metabolites"},{"issue":"2","key":"1405_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-024-02090-6","volume":"20","author":"GJ Gouveia","year":"2024","unstructured":"Gouveia GJ, Head T, Cheng LL, Clendinen CS, Cort JR (2024) Perspective: use and reuse of NMR-based metabolomics data: what works and what remains challenging. Metabolomics 20(2):41. https:\/\/doi.org\/10.1007\/s11306-024-02090-6","journal-title":"Metabolomics"},{"key":"1405_CR19","doi-asserted-by":"publisher","unstructured":"Gowda GAN, Raftery D (2019) Analysis of plasma, serum, and whole blood metabolites using 1H NMR spectroscopy. NMR-Based Metabolomics Methods in Molecular Biology, pp 17\u201334. https:\/\/doi.org\/10.1007\/978-1-4939-9690-2_2","DOI":"10.1007\/978-1-4939-9690-2_2"},{"issue":"3","key":"1405_CR20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2217\/bmm.09.22","volume":"3","author":"GAN Gowda","year":"2009","unstructured":"Gowda GAN, Ijare OB, Shanaiah N, Bezabeh T (2009) Combining nuclear magnetic resonance spectroscopy and mass spectrometry in biomarker discovery. Biomark Med 3(3):307\u2013322.\u00a0https:\/\/doi.org\/10.2217\/bmm.09.22","journal-title":"Biomark Med"},{"issue":"12","key":"1405_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143731","volume":"10","author":"X Hai","year":"2015","unstructured":"Hai X, Landeras V, Dobre M, DeOreo P, Meyer TW, Hostetter TH (2015) Mechanism of prominent trimethyl oxide (TMAO) accumulation in hemodialysis patients. PLoS ONE 10(12):e0143731.\u00a0https:\/\/doi.org\/10.1371\/journal.pone.0143731","journal-title":"PLoS ONE"},{"issue":"10","key":"1405_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12100963","volume":"12","author":"K Huang","year":"2022","unstructured":"Huang K, Thomas N, Gooley PR, Armstrong CW (2022) Systematic review of NMR-based metabolomics practices in human disease research. Metabolites 12(10):963. https:\/\/doi.org\/10.3390\/metabo12100963","journal-title":"Metabolites"},{"issue":"10","key":"1405_CR23","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/s1470-2045(06)70906-8","volume":"7","author":"RL Jones","year":"2006","unstructured":"Jones RL, Smith IE (2006) Neoadjuvant treatment for early-stage breast cancer: opportunities to assess tumour response. Lancet Oncol 7(10):869\u2013874. https:\/\/doi.org\/10.1016\/s1470-2045(06)70906-8","journal-title":"Lancet Oncol"},{"key":"1405_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jmr.2013.11.019","volume":"239","author":"M Jupin","year":"2014","unstructured":"Jupin M, Michiels P, Girard F, Spraul M, Wijmenga S (2014) NMR metabolomics profiling of blood plasma mimics shows that medium- and long-chain fatty acids differently release metabolites from human serum albumin. J Magn Reson 239:34\u201343. https:\/\/doi.org\/10.1016\/j.jmr.2013.11.019","journal-title":"J Magn Reson"},{"issue":"1","key":"1405_CR25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1146\/annurev.pharmtox.48.113006.094715","volume":"48","author":"R Kaddurah-Daouk","year":"2008","unstructured":"Kaddurah-Daouk R, Kristal BS, Weinshilboum RM (2008) Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol 48(1):653\u2013683. https:\/\/doi.org\/10.1146\/annurev.pharmtox.48.113006.094715","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"23","key":"1405_CR26","doi-asserted-by":"publisher","first-page":"11326","DOI":"10.1021\/ac402390q","volume":"85","author":"JW Kim","year":"2013","unstructured":"Kim JW, Ryu SH, Kim S, Lee HW, Lim M, Seong SJ et al (2013) Pattern recognition analysis for hepatotoxicity induced by acetaminophen using plasma and urinary 1H NMR-based metabolomics in humans. Anal Chem 85(23):11326\u201311334. https:\/\/doi.org\/10.1021\/ac402390q","journal-title":"Anal Chem"},{"issue":"1","key":"1405_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00723-016-0846-9","volume":"48","author":"J Kruk","year":"2016","unstructured":"Kruk J, Doskocz M, Jod\u0142owska E, Zacharzewska A, \u0141akomiec J, Czaja K, Kujawski J (2016) NMR techniques in metabolomic studies: a quick overview on examples of utilization. Appl Magn Reson 48(1):1\u201321. https:\/\/doi.org\/10.1007\/s00723-016-0846-9","journal-title":"Appl Magn Reson"},{"key":"1405_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jmr.2014.01.005","volume":"241","author":"JH Lee","year":"2014","unstructured":"Lee JH, Okuno Y, Cavagnero S (2014) Sensitivity enhancement in solution NMR: emerging ideas and new frontiers. J Magn Reson 241:18\u201331. https:\/\/doi.org\/10.1016\/j.jmr.2014.01.005","journal-title":"J Magn Reson"},{"issue":"9","key":"1405_CR29","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.4155\/bio.09.112","volume":"1","author":"C Legido-Quigley","year":"2009","unstructured":"Legido-Quigley C, Cloarec O, Parker DA, Murphy GM, Holmes E, Lindon JC et al (2009) First example of hepatocyte transplantation to alleviate ornithine transcarbamylase deficiency, monitored by NMR-based metabonomics. Bioanalysis 1(9):1527\u20131535. https:\/\/doi.org\/10.4155\/bio.09.112","journal-title":"Bioanalysis"},{"key":"1405_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.698337","volume":"8","author":"MPM Letertre","year":"2021","unstructured":"Letertre MPM, Giraudeau P, de Tullio P (2021) Nuclear magnetic resonance spectroscopy in clinical metabolomics and personalized medicine: current challenges and perspectives. Front Mol Biosci 8:698337. https:\/\/doi.org\/10.3389\/fmolb.2021.698337","journal-title":"Front Mol Biosci"},{"issue":"4","key":"1405_CR31","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1007\/s11306-014-0758-3","volume":"11","author":"DB Liesenfeld","year":"2014","unstructured":"Liesenfeld DB, Habermann N, Toth R, Owen RW, Frei E, B\u00f6hm J et al (2014) Changes in urinary metabolic profiles of colorectal cancer patients enrolled in a prospective cohort study (ColoCare). Metabolomics 11(4):998\u20131012. https:\/\/doi.org\/10.1007\/s11306-014-0758-3","journal-title":"Metabolomics"},{"key":"1405_CR32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jad.2015.05.00513","volume":"185","author":"C Liu","year":"2015","unstructured":"Liu C, Wu Y, Feng G, Gao X, Zhou Y, Hou W et al (2015) Plasma-metabolite-biomarkers for the therapeutic response in depressed patients by the traditional Chinese medicine formula Xiaoyaosan: a 1H NMR-based metabolomics approach. J Affect Disord 185:156\u2013163. https:\/\/doi.org\/10.1016\/j.jad.2015.05.00513","journal-title":"J Affect Disord"},{"key":"1405_CR33","doi-asserted-by":"publisher","unstructured":"Long FH (2013) Multivariate analysis for metabolomics and proteomics data. Proteomic Metab Approach Biomark Discov 299\u2013311. https:\/\/doi.org\/10.1016\/b978-0-12-394446-7.00019-4","DOI":"10.1016\/b978-0-12-394446-7.00019-4"},{"key":"1405_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/metabo10020051","volume":"10","author":"NP Long","year":"2020","unstructured":"Long NP, Nghi TD, Kang YP, Anh NH, Kim HM, Park SK, Kwon SW (2020) Toward a standardized strategy of clinical metabolomics for the advancement of precision medicine. Metabolites 10:51.\u00a0https:\/\/doi.org\/10.3390\/metabo10020051","journal-title":"Metabolites"},{"issue":"1","key":"1405_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/pca.1186","volume":"21","author":"C Ludwig","year":"2010","unstructured":"Ludwig C, Viant MR (2010) Two-dimensional J-resolved NMR spectroscopy: review of a key methodology in the metabolomics toolbox. Phytochem Anal 21(1):22\u201332. https:\/\/doi.org\/10.1002\/pca.1186","journal-title":"Phytochem Anal"},{"issue":"1","key":"1405_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1021\/acs.analchem.2c04606","volume":"95","author":"GA Nagana Gowda","year":"2023","unstructured":"Nagana Gowda GA, Raftery D (2023) NMR metabolomics methods for investigating disease. Anal Chem 95(1):83\u201399.\u00a0https:\/\/doi.org\/10.1021\/acs.analchem.2c04606","journal-title":"Anal Chem"},{"issue":"2","key":"1405_CR37","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/metabo3020373","volume":"3","author":"M Palmnas","year":"2013","unstructured":"Palmnas M, Vogel H (2013) The future of NMR metabolomics in cancer therapy: towards personalizing treatment and developing targeted drugs? Metabolites 3(2):373\u2013396. https:\/\/doi.org\/10.3390\/metabo3020373","journal-title":"Metabolites"},{"issue":"9","key":"1405_CR38","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1007\/s00216-024-05137-8","volume":"416","author":"Y Peng","year":"2024","unstructured":"Peng Y, Zhang Z, He L, Li C, Liu M (2024) NMR spectroscopy for metabolomics in the living system: recent progress and future challenges. Anal Bioanal Chem 416(9):2319\u20132334.\u00a0https:\/\/doi.org\/10.1007\/s00216-024-05137-8","journal-title":"Anal Bioanal Chem"},{"issue":"1","key":"1405_CR39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1513\/annalsats.201409-415oc","volume":"12","author":"MA Puskarich","year":"2015","unstructured":"Puskarich MA, Finkel MA, Karnovsky A, Jones AE, Trexel J, Harris BN, Stringer KA (2015) Pharmacometabolomics of L-carnitine treatment response phenotypes in patients with septic shock. Ann Am Thorac Soc 12(1):46\u201356. https:\/\/doi.org\/10.1513\/annalsats.201409-415oc","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"1405_CR40","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/metabo3020243","volume":"3","author":"MJ Rist","year":"2013","unstructured":"Rist MJ, Muhle-Goll C, G\u00f6rling B, Bub A, Heissler S, Watzl B, Luy B (2013) Influence of freezing and storage procedure on human urine samples in NMR-based metabolomics. Metabolites 3(2):243\u2013258. https:\/\/doi.org\/10.3390\/metabo3020243","journal-title":"Metabolites"},{"key":"1405_CR41","unstructured":"Rush D, Somorjai R, Deslauriers R, Shaw, Anthony S, Jeffery J, Nickerson P (2000) Subclinical rejection \u2013 a potential surrogate marker for chronic rejection \u2013 may be diagnosed by protocol biopsy or urine spectroscopy. Ann Transplant 5(2):44\u201349"},{"issue":"1","key":"1405_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2131\/jts.44.57","volume":"44","author":"SH Ryu","year":"2019","unstructured":"Ryu SH, Lee JD, Kim JW, Kim S, Kim S, Kim K-B (2019) 1H NMR toxicometabolomics following cisplatin-induced nephrotoxicity in male rats. J Toxicol Sci 44(1):57\u201371. https:\/\/doi.org\/10.2131\/jts.44.57","journal-title":"J Toxicol Sci"},{"issue":"1","key":"1405_CR43","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0924-2031(01)00148-5","volume":"28","author":"RL Somorjai","year":"2002","unstructured":"Somorjai RL, Dolenko B, Nikulin A, Nickerson P, Rush D, Shaw A et al (2002) Distinguishing normal from rejecting renal allografts: application of a three\u2014stage classification strategy to MR and IR spectra of urine. Vib Spectrosc 28(1):97\u2013102. https:\/\/doi.org\/10.1016\/S0924-2031(01)00148-5","journal-title":"Vib Spectrosc"},{"issue":"2","key":"1405_CR44","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1158\/1078-0432.CCR-08-1059","volume":"15","author":"JL Spratlin","year":"2009","unstructured":"Spratlin JL, Serkova NJ, Eckhardt SG (2009) Clinical applications of metabolomics in oncology: a review. Clin Cancer Res 15(2):431\u2013440. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-1059","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1405_CR45","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/shk.0000000000000406","volume":"44","author":"KA Stringer","year":"2015","unstructured":"Stringer KA, Younger JG, Mchugh C, Yeomans L, Finkel MA, Puskarich MA et al (2015) Whole blood reveals more metabolic detail of the human metabolome than serum as measured by 1H-NMR spectroscopy. Shock 44(3):200\u2013208. https:\/\/doi.org\/10.1097\/shk.0000000000000406","journal-title":"Shock"},{"issue":"2","key":"1405_CR46","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s11306-010-0197-8","volume":"6","author":"SJ Sumner","year":"2010","unstructured":"Sumner SJ, Burgess JP, Snyder RW, Popp JA, Fennell TR (2010) Metabolomics of urine for the assessment of microvesicular lipid accumulation in the liver following isoniazid exposure. Metabolomics 6(2):238\u2013249. https:\/\/doi.org\/10.1007\/s11306-010-0197-8","journal-title":"Metabolomics"},{"issue":"13","key":"1405_CR47","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1021\/ac051972y","volume":"78","author":"O Teahan","year":"2006","unstructured":"Teahan O, Gamble S, Holmes E, Waxman J, Nicholson JK, Bevan C, Keun HC (2006) Impact of analytical bias in metabonomic studies of human blood serum and plasma. Anal Chem 78(13):4307\u20134318. https:\/\/doi.org\/10.1021\/ac051972y","journal-title":"Anal Chem"},{"issue":"3","key":"1405_CR48","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.molonc.2012.10.003","volume":"7","author":"S Wei","year":"2012","unstructured":"Wei S, Liu L, Zhang J, Bowers J, Gowda GN, Seeger H et al (2012) Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer. Mol Oncol 7(3):297\u2013307. https:\/\/doi.org\/10.1016\/j.molonc.2012.10.003","journal-title":"Mol Oncol"},{"key":"1405_CR49","doi-asserted-by":"publisher","unstructured":"Wishart DS, Cheng LL, Copi\u00e9 V, Edison AS, Eghbalnia HR, Hoch JC, ... Uchimiya M (2022) NMR and metabolomics\u2014a roadmap for the future. Metabolites 12(8):678. https:\/\/doi.org\/10.3390\/metabo12080678","DOI":"10.3390\/metabo12080678"},{"key":"1405_CR50","doi-asserted-by":"publisher","unstructured":"Yu Z, Kastenm\u00fcller G, He Y, Belcredi P, M\u00f6ller G, Prehn C, . . . Wang-Sattler R (2011) Differences between human plasma and serum metabolite profiles. PLoS ONE 6(7). https:\/\/doi.org\/10.1371\/journal.pone.0021230","DOI":"10.1371\/journal.pone.0021230"},{"key":"1405_CR51","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/J.CCA.2012.08.016","volume":"414","author":"A Zhang","year":"2012","unstructured":"Zhang A, Sun H, Wu X, Wang X (2012) Urine metabolomics. Clin Chim Acta 414:65\u201369. https:\/\/doi.org\/10.1016\/J.CCA.2012.08.016","journal-title":"Clin Chim Acta"},{"key":"1405_CR52","doi-asserted-by":"publisher","unstructured":"Zheng H, Cai A, Zhou Q, Xu P, Zhao L, Li C et al (2017) Analytical chimica acta optimal preprocessing of serum and urine metabolomic data fusion for staging prostate cancer through design of experiment. Anal Chim Acta 1\u20138. https:\/\/doi.org\/10.1016\/j.aca.2017.09.019","DOI":"10.1016\/j.aca.2017.09.019"}],"container-title":["Biophysical Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12551-026-01405-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12551-026-01405-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12551-026-01405-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T02:20:54Z","timestamp":1772590854000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12551-026-01405-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1405"],"URL":"https:\/\/doi.org\/10.1007\/s12551-026-01405-2","relation":{},"ISSN":["1867-2450","1867-2469"],"issn-type":[{"value":"1867-2450","type":"print"},{"value":"1867-2469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}